After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

Presenter: Dr. Reena Sharma, Consultant Adult Metabolic Medicine and Honorary Senior Lecturer, Salford Royal Hospital, UK An ePoster presentation ... Spur Therapeutics is a clinical-stage ...

Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for debilitating chronic conditions. By optimizing every component of its product ...

Bicara Therapeutics Inc., a company dedicated to innovative therapies, made public its intent to furnish a corporate presentation on January 13, 2025. The presentation, as detailed in its Form 8-K ...

We list the best free presentation software, to make it simple and easy to create professional presentations without a subscription to Microsoft PowerPoint. While PowerPoint is the market leader ...

Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest and technology. Her stories hold a mirror to society, reflecting both its malaise and its beauty.

In years past, crossbow manufacturers focused on increasing bolt speed while minimizing costs. Though speed is still a focal point for new crossbows, a few other trends emerged in 2025.

Revance Therapeutics, Inc. faces financial struggles and competition, leading to a proposed takeover by Crown Labs, initially valued at $6.66 per share, later reduced to $3.10. Teoxane ...

The bad news is that the bloom may be coming off the GLP-1 rose, which is presumably the reason why not only Eli Lilly but Novo Nordisk and Viking Therapeutics stock are suffering this morning.